Synthetic biology devices and circuits for RNA-based ‘smart vaccines’: a propositional review

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Expert Review of Vaccines

• Publication date

  2015-01-14

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1586/14760584.2015.997714PMID 25566800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Self-replicating alphavirus RNA vaccines

  2015cited by this paper
• Model-driven engineering of gene expression from RNA replicons.

  2015cited by this paper
• A designer cell-based histamine-specific human allergy profiler

  2014cited by this paper
• The potential for manipulating RNA with pentatricopeptide repeat proteins.

  2014cited by this paper
• Synthetic biology in mammalian cells: next generation research tools and therapeutics

  2014cited by this paper
• Modular assembly of designer PUF proteins for specific post-transcriptional regulation of endogenous RNA

  2014cited by this paper
• High-sensitivity measurements of multiple kinase activities in live single cells.

  2014cited by this paper
• A synthetic multifunctional mammalian pH sensor and CO2 transgene-control device.

  2014cited by this paper
• Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy

  2014cited by this paper
• Expanding the RNA-recognition code of PUF proteins

  2014cited by this paper
• Aptamer-targeted Antigen Delivery

  2014cited by this paper
• Principles of genetic circuit design

  2014cited by this paper
• Synthetic riboswitches - A tool comes of age.

  2014influential reference
• A protein-RNA specificity code enables targeted activation of an endogenous human transcript

  2014cited by this paper
• mRNA-based therapeutics — developing a new class of drugs

  2014influential reference
• Sequence-based design of bioactive small molecules that target precursor microRNAs

  2014cited by this paper
• Non-viral vectors for gene-based therapy

  2014cited by this paper
• Engineering RNA-protein complexes with different shapes for imaging and therapeutic applications.

  2014influential reference
• Bidirectional regulation of mRNA translation in mammalian cells by using PUF domains.

  2014cited by this paper
• Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells.

  2013cited by this paper
• Synthetic biology: advancing the design of diverse genetic systems.

  2013cited by this paper
• A decade of riboswitches.

  2013cited by this paper
• Controlling Mammalian Gene Expression by Allosteric Hepatitis Delta Virus Ribozymes

  2013cited by this paper
• Efficient generation of human iPSCs by a synthetic self-replicative RNA.

  2013cited by this paper
• A versatile cis-acting inverter module for synthetic translational switches

  2013cited by this paper
• Quantitative and simultaneous translational control of distinct mammalian mRNAs

  2013cited by this paper
• Structural basis for the modular recognition of single-stranded RNA by PPR proteins

  2013cited by this paper
• Synthetic mammalian gene circuits for biomedical applications.

  2013cited by this paper
• Molecular mechanisms of RNA interference.

  2013cited by this paper
• RNA: the new revolution in nucleic acid vaccines.

  2013cited by this paper
• Tinkering with translation: protein synthesis in virus-infected cells.

  2013cited by this paper
• Ligand‐Dependent Upregulation of Ribosomal Shunting

  2013cited by this paper
• An in vivo RNAi screening approach to identify host determinants of virus replication.

  2013cited by this paper
• Biomedically relevant circuit-design strategies in mammalian synthetic biology

  2013cited by this paper
• RNA modularity for synthetic biology

  2013cited by this paper
• Challenges and advances towards the rational design of mRNA vaccines.

  2013cited by this paper
• MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies

  2013cited by this paper
• Reward-based hypertension control by a synthetic brain–dopamine interface

  2013cited by this paper
• From gene switches to mammalian designer cells: present and future prospects.

  2013cited by this paper
• The mechanism of eukaryotic translation initiation: new insights and challenges.

  2012cited by this paper
• Direct and specific chemical control of eukaryotic translation with a synthetic RNA–protein interaction

  2012influential reference
• Nonviral delivery of self-amplifying RNA vaccines

  2012cited by this paper
• Inducible Control of Subcellular RNA Localization Using a Synthetic Protein-RNA Aptamer Interaction

  2012cited by this paper
• Synthetic RNA switches as a tool for temporal and spatial control over gene expression.

  2012cited by this paper
• Engineering RNA Endonucleases with Customized Sequence Specificities

  2012cited by this paper
• Foundations for the design and implementation of synthetic genetic circuits

  2012cited by this paper
• Principles of translational control: an overview.

  2012cited by this paper
• A Combinatorial Amino Acid Code for RNA Recognition by Pentatricopeptide Repeat Proteins

  2012cited by this paper
• The need for innovative strategies to improve immunisation services in rural Zimbabwe.

  2012cited by this paper
• Synthetic biology with RNA: progress report.

  2012cited by this paper
• Three-dimensionally designed protein-responsive RNA devices for cell signaling regulation

  2012cited by this paper
• Destabilizing domains derived from the human estrogen receptor.

  2012cited by this paper
• Comparison of the gene transfer efficiency of mRNA/GL67 and pDNA/GL67 complexes in respiratory cells.

  2012cited by this paper
• RNA-based therapeutics: current progress and future prospects.

  2012cited by this paper
• Programmable single-cell mammalian biocomputers

  2012cited by this paper
• Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome

  2012cited by this paper
• Feedback Control of Protein Expression in Mammalian Cells by Tunable Synthetic Translational Inhibition

  2011cited by this paper
• Expression of therapeutic proteins after delivery of chemically modified mRNA in mice

  2011cited by this paper
• A Synthetic Optogenetic Transcription Device Enhances Blood-Glucose Homeostasis in Mice

  2011cited by this paper
• Synthetic RNA-protein complex shaped like an equilateral triangle.

  2011cited by this paper
• Rational design of a small molecule-responsive intramer controlling transgene expression in mammalian cells

  2011cited by this paper
• Rational design of artificial riboswitches based on ligand-dependent modulation of internal ribosome entry in wheat germ extract and their applications as label-free biosensors.

  2011cited by this paper
• Multi-Input RNAi-Based Logic Circuit for Identification of Specific Cancer Cells

  2011cited by this paper
• PUF proteins: repression, activation and mRNA localization.

  2011cited by this paper
• Synthetic Biology: Integrated Gene Circuits

  2011cited by this paper
• Combinatorially inducible RNA interference triggered by chemically modified oligonucleotides.

  2011cited by this paper
• Synthetic human cell fate regulation by protein-driven RNA switches

  2011influential reference
• Targeted translational regulation using the PUF protein family scaffold

  2011cited by this paper
• Mechanistic Basis for RNA Aptamer‐Based Induction of TetR

  2011cited by this paper
• High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice

  2011cited by this paper
• A universal code for RNA recognition by PUF proteins.

  2011cited by this paper
• Nucleoside modifications in RNA limit activation of 2′-5′-oligoadenylate synthetase and increase resistance to cleavage by RNase L

  2011cited by this paper
• Small molecule displacement of a cryptic degron causes conditional protein degradation

  2011cited by this paper
• Rationally-designed logic integration of regulatory signals in mammalian cells

  2010cited by this paper
• Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

  2010cited by this paper
• Engineering a direct and inducible protein-RNA interaction to regulate RNA biology.

  2010cited by this paper
• Design of small molecule-responsive microRNAs based on structural requirements for Drosha processing

  2010cited by this paper
• Unmet needs in modern vaccinology: adjuvants to improve the immune response.

  2010cited by this paper
• Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay

  2010cited by this paper
• Logic integration of mRNA signals by an RNAi-based molecular computer

  2010cited by this paper
• Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation

  2010cited by this paper
• A ligand-dependent hammerhead ribozyme switch for controlling mammalian gene expression.

  2010cited by this paper
• Synthetic translational regulation by an L7Ae-kink-turn RNP switch.

  2010cited by this paper
• Small self-cleaving ribozymes.

  2010cited by this paper
• Progress and prospects: nuclear import of nonviral vectors

  2010cited by this paper
• Mechanistic insights into an engineered riboswitch: a switching element which confers riboswitch activity

  2010cited by this paper
• Reprogramming Cellular Behavior with RNA Controllers Responsive to Endogenous Proteins

  2010cited by this paper
• Structure-activity relationships through sequencing (StARTS) defines optimal and suboptimal RNA motif targets for small molecules.

  2010cited by this paper
• Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems

  2010cited by this paper
• Key concepts in immunology.

  2010cited by this paper
• Self-sufficient control of urate homeostasis in mice by a synthetic circuit

  2010cited by this paper
• SnapShot: pathways of antiviral innate immunity.

  2010cited by this paper
• Principles of vaccine design-Lessons from nature.

  2010cited by this paper
• Signature amino acids enable the archaeal L7Ae box C/D RNP core protein to recognize and bind the K-loop RNA motif.

  2010cited by this paper
• A general chemical method to regulate protein stability in the mammalian central nervous system.

  2010cited by this paper
• Two-dimensional combinatorial screening and the RNA Privileged Space Predictor program efficiently identify aminoglycoside–RNA hairpin loop interactions

  2009cited by this paper
• Conditional RNA interference mediated by allosteric ribozyme.

  2009cited by this paper
• An RNA aptamer that induces transcription.

  2009cited by this paper
• Engineering splicing factors with designed specificities

  2009cited by this paper
• A fast and efficient translational control system for conditional expression of yeast genes

  2009cited by this paper

• mRNA-Based Therapeutics: Advances in Drug Delivery, Comparative Innovations, and Biomedical Applications.

  2025cites this paper
• MicroRNA-responsive ON-OFF hybrid mRNA switch for precise protein expression control

  2025cites this paper
• DNA Vaccines in the Post-mRNA Era: Engineering, Applications, and Emerging Innovations

  2025cites this paper
• Orthogonal inducible control of Cas13 circuits enables programmable RNA regulation in mammalian cells

  2024cites this paper
• Efficient in vitro and in vivo transfection of self-amplifying mRNA with linear poly(propylenimine) and poly(ethylenimine-propylenimine) random copolymers as non-viral carriers.

  2024cites this paper
• Construction of Candida albicans Adhesin-Exposed Synthetic Cells for Preventing Systemic Fungal Infection

  2023cites this paper
• Orthogonal inducible control of Cas13 circuits enables programmable RNA regulation in mammalian cells

  2023cites this paper
• Harnessing synthetic biology for advancing RNA therapeutics and vaccine design

  2023cites this paper
• The Design of 2DOF IMC-PID Controller in Biochemical Reaction Networks

  2023cites this paper
• Synthetic circular RNA switches and circuits that control protein expression in mammalian cells

  2023cites this paper
• Squaring a Circle: To What Extent Are Traditional Circuit Analogies Impeding Synthetic Biology?

  2022cites this paper
• SARS CoV-2 Vaccination Autoimmunity, Antibody Dependent Covid-19 Enhancement and Other Potential Risks: Beneath the Tip of the Iceberg

  2021cites this paper
• Translational Applications of Hydrogels

  2021cites this paper
• Virus as Quasi-Living Bio-Material for Interaction Design: Practical, Ethical, and Philosophical Implications

  2021cites this paper
• Controlling timing and location in vaccines

  2020cites this paper
• Systems and Synthetic Immunology

  2020cites this paper
• Implication of Synthetic Biology in Biotherapeutic Engineering

  2020cites this paper
• RNA and protein-based nanodevices for mammalian post-transcriptional circuits.

  2020cites this paper
• Orthogonal protein-responsive mRNA switches for mammalian synthetic biology.

  2019cites this paper
• mRNA therapeutics deliver a hopeful message

  2018cites this paper
• Synthetic switch-based baculovirus for transgene expression control and selective killing of hepatocellular carcinoma cells

  2018cites this paper
• Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids

  2018cites this paper
• Small-molecule-based regulation of RNA-delivered circuits in mammalian cells

  2018cites this paper
• Synthetic RNA-based logic computation in mammalian cells

  2018cites this paper
• Title Protein-driven RNA nanostructured devices that function invitro and control mammalian cell fate

  2018cites this paper
• Dynamic Sequence Specific Constraint-Based Modeling of Cell-Free Protein Synthesis

  2018cites this paper
• Synthetic gene circuits for the detection, elimination and prevention of disease

  2018cites this paper
• Advancing therapeutic applications of synthetic gene circuits.

  2017cites this paper
• Protein-driven RNA nanostructured devices that function in vitro and control mammalian cell fate

  2017cites this paper
• Dual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents.

  2017cites this paper
• Artificial OFF-Riboswitches That Downregulate Internal Ribosome Entry without Hybridization Switches in a Eukaryotic Cell-Free Translation System.

  2017cites this paper
• Programming dynamic nonlinear biomolecular devices using DNA strand displacement reactions

  2016cites this paper
• Control of RNA function by conformational design

  2016cites this paper
• Implementing Nonlinear Feedback Controllers Using DNA Strand Displacement Reactions

  2016cites this paper
• Engineering cell-based therapies to interface robustly with host physiology.

  2016cites this paper
• Coupling spatial segregation with synthetic circuits to control bacterial survival

  2016cites this paper
• The use of Biological Riboswitches and Ribozymes as Scaffolds for Selection and Novel RNA Devices

  2015cites this paper
• N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice.

  2015cites this paper
• An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo.

  2015cites this paper
• Antibiotic-Free Selection in Biotherapeutics: Now and Forever

  2015cites this paper
• Biomolecular implementation of a quasi sliding mode feedback controller based on DNA strand displacement reactions

  2015cites this paper
• Rational design of artificial ON-riboswitches.

  2014cites this paper